Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,457 | 270,643 | 855,435 | 831,722 | 637,308 |
| Marketable Securities | N/A | 5,726 | 26,559 | 23,079 | 10,766 |
| Receivables | N/A | 697,228 | 636,998 | 587,456 | 591,058 |
| Inventories | N/A | 403,488 | 377,866 | 323,318 | 353,222 |
| Other current assets | 0 | 248,154 | 196,759 | 280,950 | 203,810 |
| TOTAL | $37,021 | $1,625,239 | $2,093,617 | $2,046,525 | $1,796,164 |
| Non-Current Assets | |||||
| PPE Net | 2,505 | 844,692 | 833,678 | 847,984 | 829,032 |
| Investments And Advances | 0 | 26,670 | 24,990 | 22,440 | 380,160 |
| Other Non-Current Assets | 260 | 6,141,440 | 6,235,660 | 6,569,230 | 6,110,370 |
| TOTAL | $2,765 | $7,012,802 | $7,094,328 | $7,439,654 | $7,319,562 |
| Total Assets | $39,786 | $8,638,065 | $9,187,963 | $9,486,199 | $9,115,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 935 | 253,210 | 450,830 | 347,740 | 481,700 |
| Accounts payable and accrued liabilities | 1,055 | 186,560 | 178,370 | 174,440 | 237,250 |
| Accrued Expenses | 2,941 | 297,900 | 269,250 | 257,980 | 229,680 |
| Other current liabilities | N/A | 325,780 | 597,830 | 312,210 | 373,660 |
| TOTAL | $5,207 | $1,192,351 | $1,496,306 | $1,146,385 | $1,385,723 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,158 | 2,060,855 | 2,297,653 | 2,727,624 | 2,620,089 |
| Deferred Revenues | 276 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,597 | 443,970 | 384,210 | 616,170 | 390,000 |
| TOTAL | $7,496 | $2,792,245 | $3,092,423 | $3,901,774 | $3,703,339 |
| Total Liabilities | $12,703 | $3,984,602 | $4,588,737 | $5,048,170 | $5,089,072 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 2,180 | 2,110 | 2,070 | 1,960 |
| Retained earnings | -85,801 | 1,341,846 | 910,991 | 532,499 | 154,204 |
| Other shareholders' equity | 95,510 | 59,877 | 65,065 | 100,610 | 51,724 |
| TOTAL | $27,083 | $4,653,463 | $4,599,226 | $4,438,029 | $4,026,668 |
| Total Liabilities And Equity | $39,786 | $8,638,065 | $9,187,963 | $9,486,199 | $9,115,740 |